EOSS-ATTR Study (eHealth Based Operative Support System in ATTR-CM)

NANot yet recruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

December 1, 2024

Primary Completion Date

March 15, 2026

Study Completion Date

March 15, 2026

Conditions
Heart FailureAmyloid CardiomyopathyATTR Amyloidosis Wild TypeATTR Gene Mutation
Interventions
PROCEDURE

mHealth

"Follow-up and treatment of patients in the mHealth arm will be based on a comprehensive solution for the care and monitoring of chronic patients, modelled and tested in chronic HF patients. This is the PIRENe platform, previously described and evaluated in HF patients. It is a digital solution, external to the centre's information systems (external platform). However, it has some special features in its design in terms of remote monitoring, educational tools, among others, expressly conceived and designed for patients with ATTR-CM. This platform allows the provision of multichannel service and monitoring of patients through:~1. Patient monitoring of: Biometric data and symptom report.~2. Generation and management of warning alarms notified to the professionals assigned to each patient in case one of the following situations occurs.~3. Follow-up via videoconference."

All Listed Sponsors
collaborator

Institut d'Investigació Biomèdica de Bellvitge

OTHER

lead

Hospital Universitari de Bellvitge

OTHER

NCT06499064 - EOSS-ATTR Study (eHealth Based Operative Support System in ATTR-CM) | Biotech Hunter | Biotech Hunter